The efficacy and safety of convalescent plasma for COVID-19 patients: a meta-analysis based on double-blinded parallel-arm randomized placebo-controlled trials
Administration of CP to COVID-19 patients, especially those aged ≤ 60 years, may reduce mortality with excellent safety without more AEs, and serious AEs, but does not reduce the incidence of invasive mechanical ventilation.
Authors
- Jincheng Yang
- Peiyuan Liao
- Ranran Du
- Wenjing Yang
Institutions
- Qingdao University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Cancer Center (US)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1186/s12879-025-12126-4
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00